Hannah McGrenera, mum to five-year-old Mila Beukers, will be taking part alongside other big names in the Jack and Jill ...
Thousands of artworks are going on sale for a charity fundraiser where buyers will not know who the artist is until after ...
Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Here’s what you’ll learn when reading this story: For decades, the “classical view” ...
Cognito Therapeutics is partnering with a nonprofit to “Change the D-Word,” aiming to eliminate the use of “dementia,” a catchall term that can carry stigma. The term “dementia” is an umbrella term ...
Uri Alon was long puzzled by a textbook statistic: Longevity, the thinking went, was about 20 percent in our genes. “That makes you think what’s the rest of the 80 percent: Is it the lifestyle? Why ...
Perplexity’s AI search engine encourages users to go deeper with their prompts by engaging in chat sessions that a lawsuit has alleged are often shared in their entirety with Google and Meta without ...
CAMBRIDGE, Mass. and NEW ORLEANS – March 25, 2026 - Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, ...
Political leaders like United States President Donald Trump and business oligarchs like Elon Musk have increasingly suggested that human behaviour and social outcomes are rooted in genetics. Trump has ...
New findings highlight correlations between EEG and clinical outcome measures in Alzheimer’s disease Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive ...
President Donald Trump on Thursday blamed “the genetics” of assailants in a string of recent attacks across the country. He made the comments after attacks at a university in Virginia and a synagogue ...
Cognito Therapeutics, which is in late-stage development of its device to treat neurodegenerative diseases like Alzheimer’s, hauled in $105 million in an oversubscribed series C funding round. The ...
Cognito Therapeutics, a company using visual and auditory stimulation to treat neurodegenerative disorders, announced it closed an oversubscribed $105 million Series C funding round. Morningside ...